Oral sessions summaries

Acute and Chronic Complications

Results of the eValuation of ERTugliflozinEffIcacy and Safety CardioVascular Outcomes Trial (VERTIS-CV)

Richard E. Pratley, MD; Samuel Dagogo-Jack, MD, DSc; Christopher P. Cannon, MD; Darren K. McGuire, MD, MHSc; David Z. Cherney, MD, PhD; Mark E. Cooper, MBBS, PhD

ADA 2020 - Oral session

Acute and Chronic Complications

DAPA-HF Update—Have We Lost SGLT2 Inhibitors to Cardiologists?!

John J.V. McMurray, OBE, BSc (Hons), MB, ChB (Hons), MD, FRCP, FESC; Mikhail N. Kosiborod, MD; Silvio E. Inzucchi, MD; Jeffrey M. Testani, MD, MTR

ADA 2020 - Oral session

Acute and Chronic Complications

Analyses of First Plus Recurrent Cardiovascular and Hospitalization Events in the CAROLINA Trial

Nikolaus Marx, MD

ADA 2020 - Oral session

Acute and Chronic Complications

Association of Frequency of Hypoglycemic Episodes with Incident Cardiovascular Events in Adults with Type 2 Diabetes Mellitus: A National Database Study

Aman Rajpal, MD

ADA 2020 - Oral session

Clinical Diabetes/Therapeutics

Efficacy and Safety of Dulaglutide 3 mg and 4.5 mg vs. Dulaglutide 1.5 mg: 52-Week Results from AWARD-11

Juan P. Frias, MD

ADA 2020 - Oral session

Clinical Diabetes/Therapeutics

Acute Declines in eGFR During Treatment with Canagliflozin and Its Implications for Clinical Practice: Insights from CREDENCE

Megumi Oshima, MD

ADA 2020 - Oral session

Clinical Diabetes/Therapeutics

Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease

Jing Wei Li, MD

ADA 2020 - Oral session

Clinical Diabetes/Therapeutics

Quality of Life in People with Type 2 Diabetes following Initiation of Second-Line Therapy: DISCOVER

Suzanne V. Arnold, MD, MHA

ADA 2020 - Oral session

Clinical Diabetes/Therapeutics

Advanced Hybrid Closed-Loop Pivotal Safety Study

Bruce Bode, MD

ADA 2020 - Oral session

Clinical Diabetes/Therapeutics

FLAIR—An NIDDK-Sponsored International, Multisite Randomized Crossover Trial of AHCL vs. 670G

Richard M. Bergenstal, MD

ADA 2020 - Oral session

Clinical Diabetes/Therapeutics

New Zealand AHCL Randomized Crossover Trial

Martin de Bock, FRACP, PhD

ADA 2020 - Oral session

Clinical Diabetes/Therapeutics

Horizon Automated Glucose Control System Pre-pivotal Trial Data

Bruce A. Buckingham, MD

ADA 2020 - Oral session

Epidemiology/Genetics

New Data on Clinical Outcomes from the Diabetes Prevention Program Outcomes Study (DPPOS)

David M. Nathan, MD; Mark Molitch, MD; Ronald B. Goldberg, MD; Brandy M. Heckman-Stoddard, PhD, MPH;Jose A. Luchsinger-Stuart, MD, MPH

ADA 2020 - Oral session

Epidemiology/Genetics

Update from the TEDDY Study

Marian Rewers, MD, PhD; Qian Li, PhD; Kendra Vehik, PhD, MPH; William Hagopian, MD, PhD

ADA 2020 - Oral session

Epidemiology/Genetics

Twenty Years of Pediatric Diabetes Surveillance- What Do We Know and Why It Matters - The SEARCH for Diabetes in Youth Study

Jean M. Lawrence, ScD, MPH, MSSA; Amy K. Mottl, MD, MPH, FASN; Katherine A. Sauder, PhD; Catherine Pihoker, MD

ADA 2020 - Oral session

Epidemiology/Genetics

Population Health Efforts in the Prevention and Treatment of Diabetes

Natalie D. Ritchie, PhD; Matthew J. O’Brien, MD, MS; Brian J. Wells, MD, PhD; Simon Griffin, FRCGP, FMedSci

ADA 2020 - Oral session

Immunology/Transplantation

All-Cause Mortality over 16 Years in Look AHEAD

Rena R. Wing, PhD

ADA 2020 - Oral session

Immunology/Transplantation

Comparison of Pancreas vs. Islet Transplantation Outcomes from a Large Single Center

Braulio A. Marfil-Garza, MD

ADA 2020 - Oral session

Integrated Physiology/Obesity

New Insights from the Restoring Insulin Secretion (RISE) Study—Differences between Adults and Youth with Prediabetes and Type 2 Diabetes

Sharon Edelstein, ScM; Thomas A. Buchanan, MD; Kristina Utzschneider, MD; Kristen J. Nadeau, MD, MS

ADA 2020 - Oral session

Integrated Physiology/Obesity

Glycaemia, Beta-Cell Function, and Incretin Hormones Post-OGTT One Year after Gastric Bypass and Sleeve Gastrectomy in Patients with Morbid Obesity and Type 2 Diabetes: An RCT (Oseberg Study)

Farhat Fatima, MD

ADA 2020 - Oral session

Therapeutics/New Technology

Differences in Time-in-Range, Glycemic Variability, and the Glucose Management Indicator in Pregnant Women with Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes

Sarit Polsky, MD

ADA 2020 - Oral session

Poster podcasts

Acute and Chronic Complications

HbA1c Levels and Rates of Hypoglycemia with Insulin Degludec U200 and Insulin Glargine U300 Stratified by Renal Function Subgroups: Post Hoc Analysis from the CONCLUDE Trial

Lawrence A. Leiter MD FRCPC FACP FAHA FACE FACC

ADA 2020 - Poster session

Acute and Chronic Complications

Effects of Empagliflozin on Glucose Metabolism and Body Fat Composition in Patients with Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

Julia Hummel MSc, PhD

ADA 2020 - Poster session

Acute and Chronic Complications

DasiglucagonHypopal Autoinjector as a Fast and Effective Treatment for Severe Hypoglycemia: Results of a Phase 3 Trial

Timothy S Bailey, MD, FACE

ADA 2020 - Poster session

Cardiovascular

Substantial Cardiovascular Benefit from Icosapent Ethyl in Patients with Diabetes: REDUCE-IT DIABETES

Deepak L. Bhatt, MD

ADA 2020 - Poster session

Cardiovascular

Cardiovascular Outcomes with Dulaglutide vs. Liraglutide

Andy Bowe, MPH

ADA 2020 - Poster session

Foot care

Modulation of Adenine Phosphoribosyltransferase-Mediated Purine Salvage to Accelerate Diabetic Wound Healing

Guang-Huar Young, Phd

ADA 2020 - Poster session

Glucose Monitoring and Sensing

Technology Use by Age and Region in Adults with Type 1 Diabetes (T1D) in the SAGE Study

Steven Edelman, MD

ADA 2020 - Poster session

Glucose Monitoring and Sensing

Use of Real-Time CGM Is Associated with Fewer Hospitalizations Compared with SMBG in the Insulin-Treated Medicare Population

David G. Marrero, PhD

ADA 2020 - Poster session

Glucose Monitoring and Sensing

Is Real-Time CGM Superior to Flash Glucose Monitoring? Results of the Type 1 Diabetes CORRIDA Randomized Control Trial

Jan Soupal MD, PhD

ADA 2020 - Poster session

Incretin Based Therapies

Dulaglutide Has Higher Adherence and Persistence than Semaglutide and Exenatide QW: 6-Month Follow-Up from U.S. Real-World Data

Reema Mody, PhD

ADA 2020 - Poster session

Insulin Delivery Systems

Anticipating Regular Physical Activity with a New Artificial Pancreas System: A Pilot Study

Marc D. Breton, PhD

ADA 2020 - Poster session

Insulin Delivery Systems

Control-IQ Technology in the Real World: The First 30 Days

Lars Mueller, MD

ADA 2020 - Poster session

Insulin Delivery Systems

Oral Insulin (ORMD-0801) Effects on Glucose Parameters in Uncontrolled T2DM on OADs

Julio Rosenstock, MD

ADA 2020 - Poster session

Insulins

Variability of 501 Inhaled Insulin Absorption and Action

Eric Zijlstra, PhD

ADA 2020 - Poster session

Insulins

Insulin and Glucagon Coadministration in Type 1 Diabetes Prevents Hypoglycemia without Worsening Hyperglycemia

Bruce W. Bode, MD

ADA 2020 - Poster session

Nutrition

Consuming High-Fructose Corn Syrup or Sucrose-Sweetened Beverages Increases Hepatic Lipid Content and Decreases Insulin Sensitivity in Young Adults

Desiree Sigala, PhD

ADA 2020 - Poster session

Type 1 diabetes

Golimumab (GLM) Preserves ß-Cell Function and Reduces Insulin Use in Children and Young Adults with Recently Diagnosed Type 1 Diabetes (T1D): The Phase 2 T1GER Study

Teresa Quattrin, MD

ADA 2020 - Poster session

Type 1 diabetes

Association of High-Affinity Autoantibodies with High-Risk HLA Haplotypes

Taylor M. Triolo MD

ADA 2020 - Poster session

ADA 2020 Virtual Highlights are available on the Medfyle app